1. Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection. FUNCTION, 2020, 1(1): zqaa002. doi: 10.1093/function/zqaa002
2. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382:1564–1567.
3. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382(12):1177–9.
4. To KK-W, Tsang OT-Y, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020;361:1319. doi:10.1093/cid/ciaa149
5. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. The New England journal of medicine Published Online First: 2020. doi:10.1056/NEJMc2001737
6. Kirk-Bayley J, Combes J, Sunkaraneni V et al. The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Reduce Cross Infection and Protect Healthcare Workers (May 4, 2020). Available at SSRN:https://ssrn.com/ abstract=3563092 or http://dx.doi.org/10.2139/ssrn.3563092
7. Parhar HS, Tasche K, Brody RM, et al. Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery. Head Neck 2020.
8. Dexter F, Parra MC, Brown JR, et al. Perioperative COVID-19 defense: an evidence-based approach for optimization of infection control and operating room management. Anesth analg 2020
9. Eggers M. Infectious Disease Management and Control with Povidone Iodine. Infectious diseases and therapy 2019;8:581–93. doi:10.1007/s40121-019-00260-x
10. Sriwilaijaroen N, Wilairat P, Hiramatsu H, et al. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities. Virol J. 2009;6:124
11. Eggers M, Eickmann M, Zorn J. Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA). Infectious diseases and therapy 2015;4:491–501. doi:10.1007/s40121-015-0091-9
12. Eggers M, Koburger-Janssen T, Eickmann M, et al. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infectious diseases and therapy 2018;7:249–59. doi:10.1007/s40121-018-0200-7
13. Pelletier JS et al. Efficacy of Povidone-Iodine Nasal And Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). [Online] Available from URL: https://www.medrxiv.org /content/ 10.1101/2020 .05.25. 20110239v1. doi: https:// doi.org/10.1101/ 2020.05.25.20110239
14. Anderson DE et al. Povidone-Iodine demonstrates rapid in-vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease. [Online] Available from URL: https://www.researchsquare.com/article/rs-34544/v1. DOI: 10.21203/rs.3.rs-34544/v1
15. Bidra A et al. Rapid In‐Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) Using Povidone‐Iodine Oral Antiseptic Rinse. Journal of Prosthodontics. https://doi.org/10.1111/jopr.13209
16. Bidra A et al. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses. [Online] Available from URL: https://onlinelibrary. wiley.com/doi/abs /10.1111/jopr.13220. Journal of Prosthodontics https://doi. org/10.1111/jopr.13220
17. Gray PEA, Katelaris CH, Lipson D. Recurrent anaphylaxis caused by topical povidone-iodine (Betadine). J Paediatr Child Health 2013;49:506‐7 doi:10.1111/jpc.12232
18. Frank S, Capriotti J, Brown SM, et al:Povidone‐iodine use in sinonasal and oral cavities: A review of safety in the COVID‐19 era. Ear Nose Throat J May 2020. Accepted and In press.
19. Panchmatia R, Payandeh J, Al‐Salman R, et al: The efficacy of diluted topical povidone‐iodine rinses in the management of recalcitrant chronic rhinosinusitis: a prospective cohort study. Eur Arch Otorhinolaryngol 2019;276:3373‐3381
20. Kovesi G: The use of betadine antiseptic in the treatment of oral surgical, paradontological and oral mucosal diseases. Fogorvosi szemle 1999;92:243‐250
21. Cleaning and disinfection of environmental surfaces in the context of COVID-19. Interim guidance World Health Organization. [Online]. Available from URL: https://apps.who.int/iris/handle/10665/332096
22. Infection prevention and control during health care when COVID-19 is suspected. [Online] Available from URL: https://www.who.int/ publications/i/item/10665-331495.
23. American Dental Association (ADA) Interim Guidance for Minimizing Risk of COVID-19 Transmission 2020. [Online] Available from URL: https://bit.ly /3bskHOx.
24. Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients (PIIPPI). [Online] Available from URL: https://clinicaltrials.gov/ct2/show/NCT04364802.